'well within their control'? How can this be true when it is FDA that decides these things? I think NEU was surprised that FDA wanted more info before agreeing to similar endpoints to the Ph2. I don't think the vagaries of bureaucracy and human decision making are 'well within their control'
No - language has been very positive around sales and as noted many times is above the trend line that NEU expected and guided pre-launch The problem has been we jumped out of the gate very fast and growth has since slowed. Acadia are implementing a number of things to reinvigorate growth and reduce dropouts and time will tell if these are working.
NEU is materially undervalued, page-84
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.30 |
Change
0.760(4.59%) |
Mkt cap ! $2.211B | |||
| Open | High | Low | Value | Volume |
| $17.35 | $17.94 | $17.25 | $17.64M | 1.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2533 | $17.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.45 | 1254 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |